Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter M Haddad

Showing results (31-40 of 94) with videos related to

Pageof 10
Sort By:
BMJ Case Reports|November 2, 2021
Delirious mania in a patient with COVID-19 pneumoniaPeter M Haddad, Majid Alabdulla, Javed Latoo, et al.
British Journal of Clinical Pharmacology|February 15, 2018
Marketing medicines: charting the rise of modern therapeutics through a systematic review of adverts in UK medical journals (1950-1980)A Richard Green, Peter M Haddad, Jeffrey K Aronson
Journal of Psychopharmacology (Oxford, England)|September 26, 2018
Examining the 'psychopharmacology revolution' (1950-1980) through the advertising of psychoactive drugs in the British Medical JournalA Richard Green, Jeffrey K Aronson, Peter M Haddad
Journal of Psychopharmacology (Oxford, England)|November 8, 2011
Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisonsPeter M Haddad, Amlan Das, Sarvenaz Keyhani, et al.
BMJ Case Reports|December 17, 2020
Brief psychotic disorder associated with quarantine and mild COVID-19Peter M Haddad, Majid Al Abdulla, Javed Latoo, et al.
Journal of Clinical Psychopharmacology|September 4, 2010
Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes studyDiego Novick, Josep Maria Haro, Jordan Bertsch, et al.
Current Opinion in Psychiatry|March 19, 2015
Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevancePeter M Haddad, Taishiro Kishimoto, Christoph U Correll, et al.
Journal of Psychiatric and Mental Health Nursing|June 18, 2021
Support and attitudes of Qatar mental health professionals to a proposed mental health inpatient smoking ban: Results of a cross-sectional surveyAshishkumar Badanapurkar, Deborah Nelson, Sejo Varghese, et al.
Journal of Affective Disorders|November 4, 2005
Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorderDavid G Perahia, Daniel K Kajdasz, Durisala Desaiah, et al.
Neuropsychiatric Disease and Treatment|June 24, 2021
Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect ProfileMonica Zolezzi, Rawan Abouelhassan, Yassin Eltorki, et al.
Pageof 10

Showing results (31-40 of 94) with videos related to

Sort By:
Pageof 10
BMJ Case Reports|November 2, 2021
Delirious mania in a patient with COVID-19 pneumoniaPeter M Haddad, Majid Alabdulla, Javed Latoo, et al.
British Journal of Clinical Pharmacology|February 15, 2018
Marketing medicines: charting the rise of modern therapeutics through a systematic review of adverts in UK medical journals (1950-1980)A Richard Green, Peter M Haddad, Jeffrey K Aronson
Journal of Psychopharmacology (Oxford, England)|September 26, 2018
Examining the 'psychopharmacology revolution' (1950-1980) through the advertising of psychoactive drugs in the British Medical JournalA Richard Green, Jeffrey K Aronson, Peter M Haddad
Journal of Psychopharmacology (Oxford, England)|November 8, 2011
Antipsychotic drugs and extrapyramidal side effects in first episode psychosis: a systematic review of head-head comparisonsPeter M Haddad, Amlan Das, Sarvenaz Keyhani, et al.
BMJ Case Reports|December 17, 2020
Brief psychotic disorder associated with quarantine and mild COVID-19Peter M Haddad, Majid Al Abdulla, Javed Latoo, et al.
Journal of Clinical Psychopharmacology|September 4, 2010
Incidence of extrapyramidal symptoms and tardive dyskinesia in schizophrenia: thirty-six-month results from the European schizophrenia outpatient health outcomes studyDiego Novick, Josep Maria Haro, Jordan Bertsch, et al.
Current Opinion in Psychiatry|March 19, 2015
Ambiguous findings concerning potential advantages of depot antipsychotics: in search of clinical relevancePeter M Haddad, Taishiro Kishimoto, Christoph U Correll, et al.
Journal of Psychiatric and Mental Health Nursing|June 18, 2021
Support and attitudes of Qatar mental health professionals to a proposed mental health inpatient smoking ban: Results of a cross-sectional surveyAshishkumar Badanapurkar, Deborah Nelson, Sejo Varghese, et al.
Journal of Affective Disorders|November 4, 2005
Symptoms following abrupt discontinuation of duloxetine treatment in patients with major depressive disorderDavid G Perahia, Daniel K Kajdasz, Durisala Desaiah, et al.
Neuropsychiatric Disease and Treatment|June 24, 2021
Long-Acting Injectable Antipsychotics: A Systematic Review of Their Non-Systemic Adverse Effect ProfileMonica Zolezzi, Rawan Abouelhassan, Yassin Eltorki, et al.
Pageof 10